BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200922T070000
DTEND;TZID=America/New_York:20200922T080000
DTSTAMP:20260411T095610
CREATED:20200908T153527Z
LAST-MODIFIED:20200908T153553Z
UID:4314-1600758000-1600761600@carb-x.org
SUMMARY:Chatham House Webinar: Creating a New Generation of Antibiotics
DESCRIPTION:Participants include Kevin Outterson\, Executive Director of CARB-X. \nThe world needs a new generation of antibiotics to address the rapid growth in antibiotic-resistant bacteria. The UK government’s 2014 Review on Antimicrobial Resistance estimated that such bacteria could result in the deaths of 10 million people a year by 2050 and an accumulated cost of up to $100 trillion to the global economy. Despite this urgent need\, there remain few new antibiotics in development due to a lack of commercial viability for pharmaceutical companies with a 2019 Chatham House report highlighting the lack of progress being made on critical recommendations to tackle antimicrobial resistance. \nThis event will discuss the urgency of the development of new antibiotics and recent efforts to address the funding gap. What is the significance of the rise of antibiotic-resistant bacteria? What are the challenges at the intersection of increasing demand for new antibiotics and their commercial viability? Does the recent announcement of a new fund from the pharmaceutical industry represent a major shift\, or just the beginning\, of what is needed? \nParticipants: \n\nThomas Cueni\, Director General\, IFPMA\nJim O’Neill\, Chair\, Chatham House\nKevin Outterson\, Associate Fellow\, Global Health Programme\, Chatham House\nLaura Piddock\, Professor of Microbiology; Deputy Director of the\nInstitute of Microbiology and Infection\, University of Birmingham\nChair: Emma Ross\, Senior Research Fellow\, Global Health Programme\, Chatham House\n\nTo learn more\, click here.
URL:https://carb-x.org/event/chatham-house-webinar-webinar-creating-a-new-generation-of-antibiotics/
LOCATION:Webinar
END:VEVENT
END:VCALENDAR